Cargando…
Case series: Inflammatory myofibroblastic bladder tumor in regional Australia
INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION:...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113722/ https://www.ncbi.nlm.nih.gov/pubmed/33957398 http://dx.doi.org/10.1016/j.ijscr.2021.105898 |
_version_ | 1783690923410980864 |
---|---|
author | Cresser, Sam Nzenza, Tatenda Tripathy, Sagarika Hall, Rohan |
author_facet | Cresser, Sam Nzenza, Tatenda Tripathy, Sagarika Hall, Rohan |
author_sort | Cresser, Sam |
collection | PubMed |
description | INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION: We report a case series of two patients in regional Australia who were diagnosed with IMT of the urinary bladder. Both patients received computed tomography (CT) and ultrasound (US) imaging to investigate lower urinary tract symptoms (LUTS). Following initial diagnosis of a bladder tumor, both patients underwent surgery, one having a transurethral resection of bladder tumor (TURBT) with the other receiving a partial cystectomy. Histology from both surgeries revealed IMT of the urinary bladder, with the first case going on to receive a partial cystectomy to ensure clear surgical margins. Both patients recovered well post-operatively, with CT cystograms revealing water-tight bladders. Initial follow up reveals no recurrence of disease. CLINICAL DISCUSSION: IMT of the urinary bladder is an exceedingly rare clinical entity which is fortunately benign and can be well managed with appropriate surgical intervention. CONCLUSION: IMT can be well managed in regional hospitals equipped with appropriate surgical, pathological and oncological services. |
format | Online Article Text |
id | pubmed-8113722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-81137222021-05-18 Case series: Inflammatory myofibroblastic bladder tumor in regional Australia Cresser, Sam Nzenza, Tatenda Tripathy, Sagarika Hall, Rohan Int J Surg Case Rep Case Series INTRODUCTION AND IMPORTANCE: Inflammatory myofibroblastic tumor (IMT) is a rare tumor subtype that affects multiple organ systems. This case series adds a regional perspective to the literature, demonstrating rare urological cancers can be managed excellently in regional settings. CASE PRESENTATION: We report a case series of two patients in regional Australia who were diagnosed with IMT of the urinary bladder. Both patients received computed tomography (CT) and ultrasound (US) imaging to investigate lower urinary tract symptoms (LUTS). Following initial diagnosis of a bladder tumor, both patients underwent surgery, one having a transurethral resection of bladder tumor (TURBT) with the other receiving a partial cystectomy. Histology from both surgeries revealed IMT of the urinary bladder, with the first case going on to receive a partial cystectomy to ensure clear surgical margins. Both patients recovered well post-operatively, with CT cystograms revealing water-tight bladders. Initial follow up reveals no recurrence of disease. CLINICAL DISCUSSION: IMT of the urinary bladder is an exceedingly rare clinical entity which is fortunately benign and can be well managed with appropriate surgical intervention. CONCLUSION: IMT can be well managed in regional hospitals equipped with appropriate surgical, pathological and oncological services. Elsevier 2021-04-27 /pmc/articles/PMC8113722/ /pubmed/33957398 http://dx.doi.org/10.1016/j.ijscr.2021.105898 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Series Cresser, Sam Nzenza, Tatenda Tripathy, Sagarika Hall, Rohan Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title | Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title_full | Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title_fullStr | Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title_full_unstemmed | Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title_short | Case series: Inflammatory myofibroblastic bladder tumor in regional Australia |
title_sort | case series: inflammatory myofibroblastic bladder tumor in regional australia |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113722/ https://www.ncbi.nlm.nih.gov/pubmed/33957398 http://dx.doi.org/10.1016/j.ijscr.2021.105898 |
work_keys_str_mv | AT cressersam caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia AT nzenzatatenda caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia AT tripathysagarika caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia AT hallrohan caseseriesinflammatorymyofibroblasticbladdertumorinregionalaustralia |